NR1H4 and metabolic dysfunction-associated steatohepatitis: In our current study, we administered antibiotics to eliminate the gut bacteria in a mouse NASH model in vivo and evaluated the effects of GC treatment in an FXR-knockout mouse model to elucidate the underlying molecular mechanism of its control of NASH by influencing the gut microbiota and bile acid-related signaling.